CMND Announces President Trump’s Executive Order Accelerating Psychedelic Therapies for PTSD, Alcohol Use Disorder, Veteran Mental Health, FDA Breakthrough Designation, MEAI Named in H.R. 7091, Phase I/IIa Trials at Yale, Johns Hopkins
Clearmind Medicine Inc. Common Shares · Now $3.17
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS